Shanghai, China

Huanming Chen

This inventor holds 10 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignees: Shanghai Zhimeng Biopharma, Inc., Shanghai Zhimeng Biopharma Co., Ltd.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Huanming Chen. Retrieved from https://idiyas.com/inventor/huanming-chen-hmx9nmzx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 10 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Huanming Chen: Innovator in Potassium Channel Regulation

Introduction

Huanming Chen is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the area of potassium channel regulation. With a total of four patents to his name, Chen's work has the potential to impact medical treatments significantly.

Latest Patents

Chen's latest patents include a compound as a potassium channel regulator and its preparation and use. This compound, characterized by a specific structure, is designed to function as a potassium channel regulator in medicaments and pharmaceutical compositions. Another notable patent involves p-phenylenediamine derivatives, which serve as potassium channel regulators, along with their preparation methods and medical applications. These innovations highlight Chen's focus on developing effective therapeutic agents.

Career Highlights

Throughout his career, Huanming Chen has worked with notable companies such as Shanghai Zhimeng Biopharma, Inc. and Shanghai Zhimeng Biopharma Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative medical solutions.

Collaborations

Chen has collaborated with esteemed colleagues, including Bo Liang and Gang Liu. These partnerships have fostered a collaborative environment that enhances the research and development of new biopharmaceuticals.

Conclusion

Huanming Chen's contributions to potassium channel regulation through his patents and collaborations position him as a key figure in the biopharmaceutical industry. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…